http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016007145-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_61075662e7a2182bcfcf5f1d3d49fd6d |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088 |
| filingDate | 2014-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_123369020759ed516b295e2708edca63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6085bcdb48cee3b4e7fddcd02918827c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99affade0446835d3759514b6f5aa031 |
| publicationDate | 2016-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2016007145-A |
| titleOfInvention | Immune status determination method, CD4 + T cell number increase prediction method, CD4 + T cell number decrease prediction method, and kit for them |
| abstract | The present invention relates to a method for determining an immune state capable of easily and accurately determining an immune state in a patient after starting treatment with an anti-human immunodeficiency virus drug, and after starting treatment with an anti-human immunodeficiency virus drug. Method for predicting an increase in the number of CD4 + T cells in patients who have not yet started treatment with an anti-human immunodeficiency virus drug, and a simple method for predicting an increase in the number of CD4 + T cells in patients with high accuracy. And a method for predicting a decrease in the number of CD4 + T cells that can be predicted with high accuracy, and a kit for them. A detection step for detecting a transcript from a transcription start point of human immunodeficiency virus RNA to 200 bases in peripheral blood mononuclear cells and the presence or absence of the detection of the transcript are used as indicators for immunity in a patient. And a method for determining an immune state in a patient after initiating treatment with an anti-human immunodeficiency virus drug, including a step of evaluating whether or not the patient is in an activated state. [Selection figure] None |
| priorityDate | 2014-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 67.